Nearly a decade ago, radio chemists at the nuclear power startup TerraPower saw a promising opportunity in radioactive waste from Cold War weapons. And when you work for a company backed by Bill Gates and his resources, you get some leeway for running with outside-the-box ideas.
TerraPower Isotopes this week announced a milestone, becoming the first commercial-scale producer of a promising and rare isotope for cancer therapies, which is extracted from weapons waste.